http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2163791-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_741b3f48ab49782c52ece3e3c73e3c35 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L12-142 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N47-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L12-14 |
| filingDate | 1994-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9627927d83e91e405d626900a3ef310d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5572d4a9168952a59d9f7e1d450c2ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96bef4d90873e6233c604f8535ba3227 |
| publicationDate | 2003-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2163791-C |
| titleOfInvention | Anti-infective materials |
| abstract | The subject matter comprises anti-infective materials such as antimicrobial materials based upon poly(hexamethylene)biguanide having a mean molecular weight M w of 2,900 through 15,000, suitably 3,000 to 8,000, in particular 3,200 to 5,000, which are suitably in the form of a wound antiseptic and/or a wound treating material or a material for antimicrobial, antiviral, and/or antiparasitic treatment which may suitably be administered by the intravenous mode. The utilization concentration of the poly(hexamethylene)biguanide as a wound antiseptic and/or a wound treatment material suitably lies in the range of 0.001 through 0.05 wt.%, in particular 0.005 through 0.12 wt.%. As compared to the known disinfective materials based upon poly(hexamethylene)biguanide which have been utilized as wound antiseptics and wound treatment materials, the poly-(hexamethylene)biguanides utilized in the present invention have a higher mean molecular weight and demonstrate an increased microbicidal activity coupled with lower toxicity and are free of side effects on the central nervous system. |
| priorityDate | 1993-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.